Save your place

Sign in to WhoBought

Please try again later.

Lineage Cell Therapeutics, Inc. (LCTX) institutional ownership

Latest close $1.14 Jul 21, 2026
Market cap$225M 52-week range SectorHealthcare
Funds holding · Q1 2026
97
reported LCTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
59 buyers · 38 sellers

Lineage Cell Therapeutics, Inc. (LCTX) price and institutional activity

Dates

Q1 2026

$0 bought by 59 investors
Fifth Third BancorpMillennium Management LLC +57 more
Bought Sold Totals per quarter; hover a bar for the names.

Lineage Cell Therapeutics, Inc. (LCTX) institutional activity · 97

Investor Type Est. change Change Δ Own Date
Fifth Third Bancorp · New
Change +4.6M Date Q1 2026
Fifth Third Bancorp New· Q1 2026 +4.6M Q1 2026
Millennium Management LLC · Added
Change +3.5M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +3.5M Q1 2026
Armistice Capital, LLC · New
Change +3.2M Date Q1 2026
Armistice Capital, LLC New· Q1 2026 +3.2M Q1 2026
Marshall Wace, LLP · Added
Change +1.7M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.7M Q1 2026
UBS Group AG · Added
Change +1.2M Date Q1 2026
UBS Group AG Added· Q1 2026 +1.2M Q1 2026
Susquehanna International Group, LLP · Added
Change +598K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +598K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −376K −74.2% Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −280K −11.6% Q1 2026
Goldman Sachs Group Inc · Reduced
Change −269K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −269K Q1 2026
Hrt Financial LP · New
Change +232K Date Q1 2026
Hrt Financial LP New· Q1 2026 +232K Q1 2026
Bank of America Corp · Added
Change +222K Date Q1 2026
Bank of America Corp Added· Q1 2026 +222K Q1 2026
Brevan Howard Capital Management LP · New
Change +187K Date Q1 2026
Brevan Howard Capital Management LP New· Q1 2026 +187K Q1 2026
Two Sigma Investments, LP · Reduced
Change −177K Δ Own −66.6% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −177K −66.6% Q1 2026
Omers Administration Corp · Reduced
Change −174K Date Q1 2026
Omers Administration Corp Reduced· Q1 2026 −174K Q1 2026
Exoduspoint Capital Management, LP · Reduced
Change −161K Date Q1 2026
Exoduspoint Capital Management, LP Reduced· Q1 2026 −161K Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 97

Famous investor activity in Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics, Inc. (LCTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Bradsher Neal C. · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Bradsher Neal C. Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Jayasuriya Anula · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Jayasuriya Anula Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Mulroy Michael H. · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Mulroy Michael H. Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Andrews Deborah J. · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Andrews Deborah J. Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Russell Angus C. · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Russell Angus C. Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Amin Dipti · Director Grant (A) 125K
Owned 125K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Amin Dipti Director Grant (A) 125K 125K Jul 1, 2026 Jul 2, 2026
Culley Brian M. · Director, Officer Buy +$24K
Price $1.63 Qty +15K Owned 256K Trade date Mar 12, 2026 Filed date Mar 12, 2026
Culley Brian M. Director, Officer Buy $1.63 +15K +$24K 256K Mar 12, 2026 Mar 12, 2026
Culley Brian M. · Director, Officer Grant (A) 3.2M
Owned 3.2M Trade date Mar 5, 2026 Filed date Mar 6, 2026
Culley Brian M. Director, Officer Grant (A) 3.2M 3.2M Mar 5, 2026 Mar 6, 2026
Howe Jill Ann · Officer Grant (A) 1.1M
Owned 1.1M Trade date Mar 5, 2026 Filed date Mar 6, 2026
Howe Jill Ann Officer Grant (A) 1.1M 1.1M Mar 5, 2026 Mar 6, 2026
Samuel George A. III · Officer Grant (A) 900K
Owned 900K Trade date Mar 5, 2026 Filed date Mar 6, 2026
Samuel George A. III Officer Grant (A) 900K 900K Mar 5, 2026 Mar 6, 2026
Culley Brian M. · Director, Officer 2 operations 0
Owned 0 Trade date Feb 11, 2026 Filed date Feb 13, 2026
Culley Brian M. Director, Officer 2 operations 0 0 Feb 11, 2026 Feb 13, 2026
Culley Brian M. · Director, Officer Tax withholding or exercise payment (F) -$23K
Price $1.80 Qty -13K Owned 241K Trade date Feb 11, 2026 Filed date Feb 13, 2026
Culley Brian M. Director, Officer Tax withholding or exercise payment (F) $1.80 -13K -$23K 241K Feb 11, 2026 Feb 13, 2026
Samuel George A. III · Officer 2 operations 0
Owned 0 Trade date Feb 11, 2026 Filed date Feb 13, 2026
Samuel George A. III Officer 2 operations 0 0 Feb 11, 2026 Feb 13, 2026
Samuel George A. III · Officer Tax withholding or exercise payment (F) -$5K
Price $1.80 Qty -3K Owned 31K Trade date Feb 11, 2026 Filed date Feb 13, 2026
Samuel George A. III Officer Tax withholding or exercise payment (F) $1.80 -3K -$5K 31K Feb 11, 2026 Feb 13, 2026
Culley Brian M. · Director, Officer Tax withholding or exercise payment (F) -$561
Price $1.68 Qty -334 Owned 222K Trade date Dec 19, 2025 Filed date Dec 19, 2025
Culley Brian M. Director, Officer Tax withholding or exercise payment (F) $1.68 -334 -$561 222K Dec 19, 2025 Dec 19, 2025
15 of 18
15 of 18 Sign in to continue to older insider transactions.

Lineage Cell Therapeutics, Inc. (LCTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Chernett Jorey 11.4M
% of shares outstanding 5.0% Filing date Sep 26, 2025
Chernett Jorey 11.4M 5.0% Sep 26, 2025
1 of 1

Lineage Cell Therapeutics, Inc. (LCTX) ownership FAQ

Who owns LCTX?

97 reporting institutions disclosed LCTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.